News & Events | BeyondCeliac.org

Celiac Disease in the News

Celiac Disease & COVID-19 Vaccines (12/9/2020)
Beyond Celiac Chief Scientist and Strategy Officer, Salvatore Alesci, MD, PhD answers frequently asked questions about celiac disease and COVID-19 vaccines.
Special Year-End Giving Message from a Donor (12/8/2020)
Inspired by Warren Buffet, one of our most generous donors shared the message below with us to pass on to supporters like you who share a passion for our goal of driving a cure for celiac disease by 2030.
Beyond Celiac Joins Forces with National Minority Quality Forum to Target Inequities in Celiac Disease Diagnosis, Treatment (10/27/2020)
Beyond Celiac partners with NMQF to uncover diversity and disparities in celiac disease
Barb Powers Recognized For Her Ongoing Work With Beyond Celiac (10/23/2020)
Beyond Celiac is pleased to announce that Barb Powers has been chosen as the 2020 recipient of the Samuel Gee Award
Beyond Celiac Chosen as Exclusive Patient Organization to Recruit for First-Ever Phase 3 Clinical Trial (10/14/2020)
Premier patient recruiter for celiac disease research, Beyond Celiac taps extensive network to advance study with 9 Meters Biopharma

Research News

Top 5 research news stories from Beyond Celiac in 2020 (01/13/2021)
The top 5 Beyond Celiac research news story reflect concerns people with celiac disease have about neurological symptoms, COVID-19, drug development and more.
Screening only way to find all children with celiac disease, study finds (12/10/2020)
Children who have celiac disease can go undiagnosed if only those who have symptoms or risk due to family history are tested, a large screening study has found
Brain images may offer clues to gluten sensitivity (12/8/2020)
A small study of people with gluten sensitivity is thought to be the first to look at brain images to investigate neurological symptoms.
Modern research tools could improve ways to diagnose celiac disease, recent study finds (11/20/2020)
New ways of measuring how those with celiac disease respond to gluten could lead to less invasive, lower-dose and shorter gluten challenges for diagnosis and in clinical trials, a new study has found.
Beyond Celiac Drives Recruitment for Promising Anokion Clinical Trial (11/18/2020)
Celiac disease community is an integral part of research into this potential immune tolerance treatment

Answers from a Dietitian®

Celiac Disease and Diverticulitis (09/3/2020)
Foods for when you suffer from both celiac disease and diverticulitis
Follow-Up Testing (05/22/2018)
Monitoring celiac disease
Ongoing Symptoms (05/22/2018)
How to tell if ongoing symptoms are from celiac disease
Why Monitor (05/22/2018)
What’s the point of follow-up testing and monitoring?
Gluten-Free vs. Wheat-Free (10/21/2016)
Are gluten-free and wheat-free the same?

Drug Development News

Beyond Celiac Drives Recruitment for Promising Anokion Clinical Trial (11/18/2020)
Celiac disease community is an integral part of research into this potential immune tolerance treatment
Larazotide Acetate still leading the pack (11/10/2020)
Recruitment of symptomatic participants in the first celiac disease Phase 3 clinical trial continues
New celiac disease drug candidate, KAN-101, in Phase 1 clinical trials (10/27/2020)
New potential treatment for celiac disease aims to re-educate the immune system so it does not react to gluten
Phase 2 study relaunching in November (10/14/2020)
Celiac disease study postponed due to COVID-19 is relaunching in November
Launch of new late-stage Phase 2b study for celiac disease patients who continue to have symptoms while on a gluten-free diet (09/2/2020)
A trial that launched in late August will test PRV-015 in symptomatic celiac disease patients

We’re putting the EMPHASIS back on CELIAC DISEASE .